Companies /Healthcare

Merck & Co Inc

NYSE: MRK Drug Manufacturers - General
$143.93
▼ $0.78 (−0.54%) today
Markets closed · 7:56pm ET

MRK Coverage

Page 44
4:01pm ET
Investing

The 4 Stocks That Buoyed the Dow on Wednesday

ThinkstockOctober 28, 2015: Markets opened higher on Wednesday and bounced of intra-day lows following the FOMC announcement which led investors to believe that interest rates may rise in December. Energy markets were…

Paul Ausick
9:10am ET
Industrials

5 Dow Stocks Reporting Earnings This Week

24/7 Wall St. has put together a preview of Apple, Exxon and some of the major Dow Jones Industrial Average companies that are reporting their quarterly results this week.

Chris Lange
4:01pm ET
Investing

The 4 Stocks That Dominated the DJIA on Thursday

ThinkstockOctober 22, 2015: Markets opened higher on Thursday on a better-than-expected report on new claims for unemployment benefits, but the better news for investors is that European Central Bank is ready to…

Paul Ausick
4:01pm ET
Investing

The 4 Stocks That Weighed on the Dow Tuesday

ThinkstockOctober 20, 2015: Markets opened lower on again on Tuesday as investors trailed along after mixed Asian and European equities markets. In Europe prospects for further central bank easing dimmed, while in…

Paul Ausick
4:01pm ET
Investing

The 4 Stocks That Lifted the DJIA on Friday

ThinkstockOctober 16, 2015: Markets opened higher on Friday following an expected drop of 0.2% in U.S. industrial production and a surprise jump of 2.5 points in the consumer sentiment index. Crude oil…

Paul Ausick
4:01pm ET
Investing

The 4 Stocks That Sank the Dow on Tuesday

thinkstockOctober 13, 2015: Markets opened lower on Tuesday following disappointing economic data from China and a lack of any U.S. data, good or bad. All sectors traded in the red with about…

Paul Ausick
4:01pm ET
Investing

The 4 Stocks That Boosted the Dow on Wednesday

thinkstockOctober 7, 2015: Markets opened higher on Wednesday tagging along on a rise in European equities. The upbeat start gave way to a loss of enthusiasm following the release of U.S. crude…

Paul Ausick